title: The role of nitric oxide in development of topographic precision in the retinotectal projection of chick.
abstract: The axonal projection from the retina to the tectum exhibits a precise topographic order in the mature chick such that neighboring ganglion cells send axons to neighboring termination zones in the contralateral tectum. The initial pattern formed during development is much less organized and is refined to the adult pattern during a discrete period of development. Refinement includes elimination of radically aberrant projections, such as those from the temporal side of the retina to posterior regions of the tectum, as well as a more subtle improvement in the topographic precision of the projection. The enzyme that synthesizes nitric oxide is expressed at high levels in the tectum during the developmental period in which the topography improves. Pharmacological blockade of nitric oxide synthesis during this period prevented elimination of topographically inappropriate retinotectal projections in a dose-dependent manner. This effect could not be duplicated by treatment of embryos with a vasoconstrictor, indicating that vascular changes were not a factor. These results show that nitric oxide is involved in refinement of the topography of the retinotectal projection as well as in other aspects of refinement of this projection in developing chick.
authors.affiliation: Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, USA.
authors.forename: H H
authors.initials: HH
authors.lastname: Wu
authors.forename: D J
authors.initials: DJ
authors.lastname: Selski
authors.forename: E E
authors.initials: EE
authors.lastname: El-Fakahany
authors.forename: S C
authors.initials: SC
authors.lastname: McLoon
mesh_terms: D000818:Animals; D002642:Chick Embryo; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008863:Microspheres; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019335:Nitroarginine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D012160:Retina / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D012165:Retinal Ganglion Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D013477:Superior Colliculi / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014795:Visual Pathways / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D019335:Nitroarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester